The price-to-earning (P/E) ratios of a few pharmaceutical stocks are currently higher than the industry average of 12.21, indicating expectations of good results from these companies.

For instance, Astra Zeneca

More From This Section

First Published: Oct 30 2002 | 12:00 AM IST

Next Story